The Department of Radiology

Dustin R. Osborne, PhD

Professor
Molecular Imaging and Translational Research Program

https://orcid.org/0000-0003-1324-5464

Research Focus

The Molecular Imaging and Translational Research program focuses on the development and translation of new molecular imaging and radiochemistry technologies and services. Dr. Osborne and colleagues are currently working on a patented respiratory and head motion correction technology for positron emission tomography (PET) cancer and Alzheimer's imaging. Recently he has developed a novel method for quantitatively testing toxic residual elements in radiopharmaceuticals that may be present as part of the production process. In addition to investigator initiated studies, Dr. Osborne offers clinical trials services and research support for imaging studies, working with partners around the globe on clinically translating new imaging compounds and technologies.

Education

Graduate School
Ph.D., Nuclear Engineering, University of Tennessee, 2006-2011
M.S., Physics: Medical Imaging Physics, University of Tennessee, Knoxville, TN, 2003-2005

Internship
Graduate Research, CITDP, Univeristy of Tennessee Graduate School of Medicine, 2004 - 2006

Certifications

American Board of Nuclear Science in Medicine: Nuclear Medicine Physics & Instrumentation
American Board of Radiology: Board Eligible

Awards and Honors

Selected for and graduated from prestigious Siemens Learning Campus 20-month leadership program
2012 Society of Nuclear Medicine Poster Award Nominee: Honorable Mention
2014 Society of Nuclear Medicine and Molecular Imaging Computer and Instrumentation Council Young Investigator Award

Professional Affiliations

Society of Nuclear Medicine
International Electrical and Electronics Engineers

Current Publications

Tumpa TR, Acuff SN, Gregor J, Bradley Y, Fu Y, Osborne DR.
Data-driven head motion correction for PET using time-of-flight and positron emission particle tracking techniques. PLoS One. 2022 Aug 31;17(8):e0272768. doi: 10.1371/journal.pone.0272768. eCollection 2022.

Current Presentations

Hatcher P, Culp S, Gall CV, Osborne D, Fu Y, Moolupuri A, Whitaker D. A phase 1,open-label, multi-center, non-randomized study of [f-18]sms-5368 positron emission tomogrphy in prostate cancer patients with biochemical recurrence and negative. conventional imaging Presented at AUA2024 (American Urological Association); 2024 May - 3; San Antonio, TX.

Hatcher P, Culp S, Gall CV, Osborne D, Fu Y, Moolupuri A, Whitaker D. A phase 1, open-label, multi-center, non-randomized study of [f-18]sms-5368 positron emission tomogrphy in prostate cancer patients with biochemical recurrence and negative conventional imaging. Presented at American Urologuc Association Annual Meeting; 2024 May - 1; San Antonio.

Muscarella KR, Eberts PT, Craig-Owens LD, Groark EK, Osborne DR, Osborne T, Stephens CD, Nodit LM. Contamination of serous effusions by sodium carboxymethyl cellulose artifact from collection canister lids. Presented at United States and Canadian Academy of Pathology Annual Meeting; 2024 March - 28; Baltimore ,Maryland.